Lces as modifiers of the p53 pathway and methods of use

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/00 (2006.01) C12P 21/06 (2006.01) C12Q 1/527 (2006.01) C12Q 1/68 (2006.01) G01N 33/50 (2006.01) G01N 33/53 (2006.01) G01N 33/567 (2006.01) G01N 33/573 (2006.01) G01N 33/574 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2448112

Human LCE genes are identified as modulators of the p53 pathway, and thus are therapeutic targets for disorders associated with defective p53 function. Methods for identifying modulators of p53, comprising screening for agents that modulate the activity of LCE are provided.

L'invention concerne des gènes humains LCE identifiés comme étant des modulateurs de la voie p53 et, par conséquent, des cibles thérapeutiques pour des troubles associés à une fonction défectueuse de p53. L'invention concerne également des procédés d'identification de modulateurs de p53 consistant à effectuer un criblage d'agents modulant l'activité des LCE.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Lces as modifiers of the p53 pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lces as modifiers of the p53 pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lces as modifiers of the p53 pathway and methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2018656

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.